Please login to the form below

Not currently logged in

    Pharmaceutical Market Europe (PME)

    PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

    From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

    PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Research

Russia says its Sputnik V COVID-19 vaccine is 91.4% effective

PutinPreliminary data demonstrates efficacy of 95% after 42 days

From: Marketing

PMEA 2020: continuing to recognise excellence in improving patient outcomes

ZoeThe 20th annual PMEAs took place virtually this year due to COVID-19

From: Marketing

PMEA Awards 2020

PMEA 2020Watch the event live from 4pm today – join us at

From: Sales

EU buys 160 million doses of Moderna’s COVID-19 vaccine

EU flagDeal follows positive data readout last week


Pharmaceutical Market Europe - November 2020

The challenge of crowded digital channels, GSK’s Peter Howarth, why vaccinations are important, and the power of behaviour change

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Have your say...

OPEN Health names Rob Barker chief executive officer

Barker succeeds outgoing OPEN Health CEO and co-founder David Rowley

Rob Barker

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

The chief executive ostrich

Some of the most perplexing executive behaviour is simply Darwinian


COVID-19 Updates and Daily News

Featured jobs


Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...